Pharmacological Treatment of Arterial Hypertension in Children and Adolescents: A Network Meta-Analysis
暂无分享,去创建一个
F. D’Ascenzo | G. Saint-Hilary | F. Veglio | P. Mulatero | S. Monticone | J. Burrello | F. Rabbia | E. Erhardt
[1] Wilbert S Aronow,et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.
[2] J. Ioannidis,et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis , 2018, The Lancet.
[3] S. Daniels,et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents , 2017, Pediatrics.
[4] Josemir W Sander,et al. Antiepileptic drug discontinuation by people with epilepsy in the general population , 2017, Epilepsia.
[5] M. Vervloet,et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. , 2017, Kidney international.
[6] S. Bangalore,et al. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. , 2017, The American journal of medicine.
[7] A. Dominiczak,et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. , 2016, Journal of hypertension.
[8] M. Flechtner-Mors,et al. Blood pressure in 57,915 pediatric patients who are overweight or obese based on five reference systems. , 2015, The American journal of cardiology.
[9] Harry Hemingway,et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people , 2014, The Lancet.
[10] Stephen G. Miller,et al. Anti-hypertensive drugs in children and adolescents. , 2014, World journal of cardiology.
[11] N. Welton,et al. Evidence Synthesis for Decision Making 3 , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[12] Jeroen P Jansen,et al. Network meta‐analysis of individual and aggregate level data , 2012, Research synthesis methods.
[13] J. Flynn,et al. Antihypertensive Drug Use By Children: Are the Drugs Labeled and Indicated? , 2012, Journal of clinical hypertension.
[14] D. Blowey,et al. Update on the Pharmacologic Treatment of Hypertension in Pediatrics , 2012, Journal of clinical hypertension.
[15] Shannon Cope,et al. Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes , 2012, BMC Medical Research Methodology.
[16] Nicky J Welton,et al. Evidence Synthesis for Decision Making in Healthcare: Welton/Evidence Synthesis for Decision Making in Healthcare , 2012 .
[17] H. Sesso,et al. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). , 2011, Journal of the American College of Cardiology.
[18] V. Shi,et al. The Efficacy and Safety of Valsartan in Obese and Non‐Obese Pediatric Hypertensive Patients , 2011, Journal of clinical hypertension.
[19] N. Welton,et al. Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment , 2011 .
[20] M. Litwin,et al. Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension , 2011, Journal of clinical hypertension.
[21] F. Rasmussen,et al. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts , 2011, BMJ : British Medical Journal.
[22] M. Litwin,et al. Regression of target organ damage in children and adolescents with primary hypertension , 2010, Pediatric Nephrology.
[23] R. Portman,et al. Safety, Efficacy, and Pharmacokinetics of Telmisartan in Pediatric Patients With Hypertension , 2010, Clinical pediatrics.
[24] A. Rudich,et al. Progression of Normotensive Adolescents to Hypertensive Adults: A Study of 26 980 Teenagers , 2010, Hypertension.
[25] J. Flynn,et al. The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: a randomized, double-blind, dose-response study. , 2010, The Journal of pediatrics.
[26] R. Heyrman,et al. A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension , 2010, Hypertension.
[27] R. Hanson,et al. Childhood obesity, other cardiovascular risk factors, and premature death. , 2010, The New England journal of medicine.
[28] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[29] Youfa Wang,et al. Tracking of Blood Pressure From Childhood to Adulthood: A Systematic Review and Meta–Regression Analysis , 2008, Circulation.
[30] T. Seeman,et al. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy. , 2007, American journal of hypertension.
[31] Michael Böhm,et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension , 2007, Blood pressure.
[32] B. Falkner,et al. Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience. , 2007, The Journal of pediatrics.
[33] F. Assadi. Effect of Microalbuminuria Lowering on Regression of Left Ventricular Hypertrophy in Children and Adolescents with Essential Hypertension , 2006, Pediatric Cardiology.
[34] M. Litwin,et al. Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension , 2006, Pediatric Nephrology.
[35] David Toll,et al. How Do You Improve Compliance? , 2005, Pediatrics.
[36] Zhongxin Zhang,et al. A double-blind, dose-response study of losartan in hypertensive children. , 2005, American journal of hypertension.
[37] G. Lu,et al. Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.
[38] R. Califf,et al. Is the Extrapolated Adult Dose of Fosinopril Safe and Effective in Treating Hypertensive Children? , 2004, Hypertension.
[39] S. Daniels,et al. A randomized, placebo-controlled trial of amlodipine in children with hypertension. , 2004, The Journal of pediatrics.
[40] Paul Landais,et al. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. , 2004, Journal of clinical epidemiology.
[41] S. Shahinfar,et al. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. , 2003, American journal of hypertension.
[42] Thomas Lumley,et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.
[43] R. Portman,et al. Clinical trial of extended-release felodipine in pediatric essential hypertension , 2003, Pediatric Nephrology.
[44] S. Shahinfar,et al. A Double‐Blind, Placebo‐Controlled, Dose‐Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension , 2002, Journal of clinical pharmacology.
[45] J. Sorof,et al. β-Blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial , 2002, Pediatric Nephrology.
[46] J. Sorof,et al. Ambulatory Blood Pressure and Left Ventricular Mass Index in Hypertensive Children , 2002, Hypertension.
[47] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[48] T. Ruddy,et al. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators. , 1998, American journal of hypertension.
[49] A Whitehead,et al. Borrowing strength from external trials in a meta-analysis. , 1996, Statistics in medicine.
[50] W. Stigelman,et al. Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .
[51] V. Bykerk,et al. Consensus Statement , 2004, Pediatric Clinical Practice Guidelines & Policies.
[52] T. Lehtimäki,et al. The Cardiovascular Risk in Young Finns Study , 2008 .